PropertyValue
?:abstract
  • ACCURATE DIAGNOSTIC TESTS THAT PROVIDE RESULTS IN A TIMELY MANNER ARE ESSENTIAL FOR THE CLINICAL AND PUBLIC HEALTH MANAGEMENT OF COVID-19 DISEASE: THE CHOICE AS TO WHICH TEST TO USE WILL DEPEND ON THE CLINICAL PRESENTATION AND THE STAGE OF THE ILLNESS: NUCLEIC ACID TESTS, USING REAL-TIME REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION, ARE THE MOST APPROPRIATE FOR DIAGNOSING ACUTE INFECTION. COMBINED DEEP NASAL (OR NASOPHARYNGEAL) AND THROAT SWABS ARE THE PREFERRED SAMPLE: SEROLOGY CAN BE USED TO DIAGNOSE PREVIOUS INFECTION, MORE THAN 14 DAYS AFTER THE ONSET OF SYMPTOMS: ANTIGEN TESTS ARE IN DEVELOPMENT AND THEIR ROLE IS NOT YET DEFINED: INTERPRETATION OF RESULTS MUST TAKE INTO ACCOUNT THE PRE-TEST PROBABILITY OF THE PATIENT HAVING THE DISEASE. THIS IS BASED ON THEIR CLINICAL PRESENTATION AND EPIDEMIOLOGICAL RISK:
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.18773/austprescr.2020.067
?:journal
  • Aust_Prescr
?:license
  • cc-by-nc-nd
?:pdf_json_files
  • document_parses/pdf_json/97d97357fb6a8f90b113a141a13c46d448fd49d7.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7738692.xml.json
?:pmcid
?:pmid
?:pmid
  • 33363303.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Testing for COVID-19
?:type
?:year
  • 2020-10-15

Metadata

Anon_0  
expand all